References
- HeDDWangCFCaoLLEpidemic trend of female breast cancer incidence in Min Hang District, ShanghaiChina Cancer201013108110
- PapamichailMPerezSAGritzapisADBaxevanisCNatural killer lymphocytes: biology, development, and functionCancer Immunol Immunother20045317618614685782
- BironCABrossayLNK cells and NKT cells in innate defense against viral infectionsCurr Opin Immunol20011345846411498302
- HerbermanRBCancer immunotherapy with natural killer cellsSemin Oncol200229273012068385
- HallettWHMurphyWJPositive and negative regulation of natural killer cells: therapeutic implicationsSemin Cancer Biol20061636738216934486
- NgoMCRooneyCMHowardJMHeslopHEEx vivo gene transfer for improved adoptive immunotherapy of cancerHum Mol Genet201120R93R9921415041
- LeeMYKimHJKimMANek6 is involved in G2/M phase cell cycle arrest through DNA damage induced phosphorylationCell Cycle200872705270918728393
- WallaceAKapoorVSunJTransforming growth factor-β receptor blockade augments the effectiveness of adoptive T-cell therapy of established solid cancersClin Cancer Res2008143966397418559619
- KellyRJMorrisJCTransforming growth factor-beta: a target for cancer therapyJ Immunotoxicol20107152619916703
- IkushimaHMiyazonoKTGF-beta signalling: a complex web in cancer progressionNat Rev Cancer20101041542420495575
- FrieseMAWischhusenJWickWRNA interference targeting transforming growth factor-beta enhances NKG2D mediated antiglioma immune response, inhibits glioma cell migration and invasiveness, and abrogates tumorigenicity in vivoCancer Res2004647596760315492287
- LeeJCLeeKMKimDWHeoDSElevated TGF-beta1 secretion and down-modulation of NKG2D underlies impaired NK cytotoxicity in cancer patientsJ Immunol20041727335734015187109
- PratAPerouCMDeconstructing the molecular portraits of breast cancerMol Oncol2011552321147047
- Diaz-MonteroCMSalemMLNishimuraMIGarrett-MayerEColeDJMonteroAJIncreased circulating myeloid-derived suppressor cells correlate with clinical cancer stage, metastatic tumor burden, and doxorubicin-cyclophosphamide chemotherapyCancer Immunol Immunother200958495918446337
- PolatMFTaysiSPolatSElevated serum arginase activity levels in patients with breast cancerSurg Today20033365566112928840
- de SouzaAPBonorinoCTumor immunosuppressive environment: effects on tumor-specific and nontumor antigen immune responsesExpert Rev Anticancer Ther200991317133219761435
- DomschkeCSchuetzFGeYIntratumoral cytokines and tumor cell biology determine spontaneous breast cancer-specific immune responses and their correlation to prognosisCancer Res2009698420842819843863
- HeldinCHLandströmMMoustakasAMechanism of TGF-beta signaling to growth arrest, apoptosis, and epithelial-mesenchymal transitionCurr Opin Cell Biol2009216617619237272
- WrzesinskiSHWanYYFlavellRATransforming growth factor-β and the immune response: implications for anticancer therapyClin Cancer Res2007135262527017875754
- CraneCAHanSJBarryJJTGF-beta downregulates the activating receptor NKG2D on NK cells and CD8+ T cells in glioma patientsNeuro Oncol20101271320150362
- TianMSchiemannWPThe TGF-β paradox in human cancer: an updateFuture Oncol2009525927119284383
- MassagueJGomisRRThe logic of TGF-β signalingFEBS Lett20065802811282016678165
- MassagueJSeoaneJWottonDSmad transcription factorsGenes Dev2005192783281016322555
- RunyanCEHayashidaTHubchakSCurleyJFSchnaperHWRole of SARA (SMAD anchor for receptor activation) in maintenance of epithelial cell phenotypeJ Biol Chem200928425182519
- ChaudhuryAHusseyGSRayPSJinGFoxPLHowePHTGF-β-mediated phosphorylation of hnRNP E1 induces EMT via transcript-selective translational induction of Dab2 and ILEINat Cell Biol20101228629320154680
- HusseyGSChaudhuryADawsonAEIdentification of an mRNP complex regulating tumorigenesis at the translational elongation stepMol Cell20114141943121329880